Preventive effect of aminoguanidine compared to vitamin E and C on cisplatin-induced nephrotoxicity in rats

Experimental and Toxicologic Pathology

Volumn 61, Issue 1, 2009, Pages 23-32

  Atasayar, S ^a   Gurer Orhan H ^b   Orhan, H ^b   Gurel B ^a   Girgin, G ^a   Ozgunes H ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

Aminoguanidine; Cisplatin; Glutathione; Malondialdehyde; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; AMINOGUANIDINE; ASCORBIC ACID; CISPLATIN; CREATININE; GLUTATHIONE; MALONALDEHYDE; UREA; ANTINEOPLASTIC AGENT; ANTIOXIDANT; ENZYME INHIBITOR; GUANIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; KIDNEY; KIDNEY TUBULE DISORDER; LIVER; LIVER LEVEL; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; SAMPLE; UREA BLOOD LEVEL; VASCULITIS; ANIMAL; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY DISEASES; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ASCORBIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CISPLATIN; ENZYME INHIBITORS; GLUTATHIONE; GUANIDINES; KIDNEY DISEASES; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; UREA; VITAMIN E;

RATTUS;

EID: 58949089601     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2008.04.016     Document Type: Article

References (44)

1. Ahn D.U., and Kim S.M. Effect of superoxide and superoxide-generating systems on the prooxidant effect of iron in oil emulsion and raw turkey homogenates. Poult Sci 77 (1998) 1428-1435
2. Appenroth D., Fröb S., Kersten L., Splinter F.K., and Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol 71 (1997) 677-683
3. Arruda W.A., Engelstad J., and Dyck P.D. Neuropathologic and morphometric effects of aminoguanidine on rat nerves. J Neurol Sci 113 (1992) 80-84
4. Atessahin A., Ceribasi A.O., Yuce A., Bulmus O., and Cikim G. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats. Basic Clin Pharmacol Toxicol 100 (2006) 121-126
5. Bogin E., Marom M., and Levi Y. Changes in serum, liver and kidney of cisplatin treated rats, effect of antioxidants. Eur J Clin Chem Clin Biochem 32 (1994) 43-51
6. Borch R.F., and Pleasants M.E. Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in rat model. Proc Natl Acad Sci 76 (1979) 6611-6614
7. Borek C. Dietary antioxidant and human cancer. Integr Cancer Ther 3 (2004) 333-341
8. Bowry V.W., Mohr D., Cleary J., and Stocker J. Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J Biol Chem 270 (1995) 5756-5763
9. Burcham P.C., Kaminskas L.M., Fontaine F.R., Peterson D.R., and Pyke S.M. Aldehyde sequestering drugs: tools for studying protein damage by LP products. Toxicolology 27 (2002) 229-236
10. Draper H.H., Squires E.J., Mamoodi H., Wu J., Agarwal M., and Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radical Biol Med 15 (1993) 353-363
11. Durak I., Ozbek H., Karaayvaz M., and Ozturk H.S. Cisplatin induces acute renal failure by impairing antioxidant system in guinea pigs: effects of antioxidant supplementation on cisplatin nephrotoxicity. Drug Chem Toxicol 25 (2002) 1-8
12. Fang Y.Z., Yang S., and Wu G. Free radicals, antioxidants, and nutrition. Nutrition 18 (2002) 872-879
13. Greggi-Antunes L.M., Darin J.D., and Bianchi M.D. Protective effect of vitamin C against cisplatin induced nephrotoxicity and LP in adult rats: a dose dependent study. Pharmacol Res 41 (2000) 405-411
14. Halliwell B., and Gutteridge J.M.C. Free radicals in biology and medicine (1989), Clarendion Press, Oxford
15. Hanigan M.H., and Devarajan P. Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther 1 (2003) 47-61
16. Hanneman J., and Baumann K. Cisplatin induced LP and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology 51 (1988) 119-132
17. Heinecke J.W. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler Thromb Vasc Biol 21 (2001) 1261-1264
18. Hinson J.A., Bucci T.J., Irwin L.K., Michael S.L., and Mayeux P.R. Effect of inhibitors of nitric oxide synthase on acetominophen induced hepatotoxity in mice. Nitric Oxide 6 (2002) 160-167
19. Jedidi I., Therond P., Zarev S., Cosson C., Couturier M., Massot C., et al. Paradoxal protective effect of aminoguanidine toward low-density lipoprotein oxidation: inhibition of apolipoprotein B fragmentation without preventing its carbonylation. Mechanism of action of aminoguanidine. Biochemistry 42 (2003) 11356-11365
20. Jianmongkol S., Vuletich J.L., Bender A.T., Demady D.R., and Osawa Y. Aminoguanidine-mediated inactivation and alteration of neuronal nitric-oxide synthase. J Biol Chem 275 (2000) 13370-13376
21. Ladas E.J., Jacobson J.S., Kennedy D.D., Teel K., Fleischauer A., and Kelly K.M. Antioxidants and cancer therapy: a systematic review. J Clin Oncol 22 (2004) 517-528
22. Lieber E., and Smith G.B.L. The chemistry of aminoguanidine and related substances. Chem Rev 25 (1939) 213-271
23. Liu J., Liu Y., Habeebu S.S.M., and Klaassen C.D. Metallothionein (Mt)-null mice are sensitive to cisplatin induced hepatotoxicity. Toxicol Appl Pharmacol 149 (1998) 24-31
24. Mansour M.A., Mostafa A.M., Nagi M.N., Khattab M.M., and Al-Shabanah O.A. Protective effect of aminoguanidine against nephrotoxicity induced by cisplatin in normal rats. Comp Biochem Physiol Part C 132 (2002) 123-128
25. Mustafa A., Gado A.M., Al-Shabanah O.A., and Al-Bekairi A.M. Protective effect of aminoguanidine against paraquat induced oxidative stress in the lung of mice. Comp Biochem Physiol Part C 132 (2002) 391-397
26. Niki E. Antioxidants in relation to LP. Chem Phys Lipids 44 (1987) 227-253
27. Nilsson B.O. Biological effects of aminoguanidine: an update. Inflamm Res 48 (1999) 509-515
28. Nordberg J., and Arner A.S.J. Reactive oxygen species, antioxidants, and mammalian thioredoxin system. Free Radical Biol Med 31 (2001) 1287-1312
29. Ou P., and Wolff S.P. Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem Pharmacol 46 (1993) 1139-1144
30. Pace A., Savarese A., Picardo M., Maresca V., Pacetti U., Del Monte G., et al. Neuroprotective effect of vitamin E supplementation in patient treated with cisplatin chemotherapy. J Clin Oncol 21 (2003) 927-931
31. Sadzuka Y., Shoji T., and Takino Y. Change of lipid peroxide levels in rat tissues after cisplatin administration. Toxicol Lett 57 (1991) 159-166
32. Sadzuka Y., Shoji T., and Takino Y. Mechanism of the increase in lipid peroxide induced by cisplatin in the kidneys of rats. Toxicol Lett 62 (1992) 293-300
33. Sanha E., Parlakpinar H., Cihan O.F., Turkoz Y., and Acet A. Effects of aminoguanidine against renal ischemia reperfusion injury in rats. Cell Biochem Funct 24 (2004) 137-141
34. Scaccini C., Chiesa G., and Jiala I. A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL: evidence for interference with some assays of lipoprotein oxidation by aminoguanidine. J Lipid Res 35 (1994) 1085-1092
35. Schneider C. Chemistry and biology of vitamin E. Mol Nutr Food Chem 49 (2005) 7-30
36. Schuppe-Koistinen I., Frisk A.L., and Janzon L. Molecular profiling of hepatotoxicity induced by a aminoguanidine carboxylate in the rat: gene expression profiling. Toxicolology 179 (2002) 197-219
37. Sheikh-Hamad D., Cacini W., Buckley A.R., Isaac J., Truong L.D., Tsao C.C., et al. Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Arch Toxicol 78 (2004) 147-155
38. Sueishi K., Mishima K., Makino K., Itoh Y., Tsuraya K., Hirakata H., et al. Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur J Pharmacol 451 (2002) 203-208
39. Templar J., Kon S.P., Milligan T.P., Newman D.J., and Raftery M.J. Increased plasma malondialdehyde levels in glomerular disease as determined by a fully validated HPLC method. Nephrol Dial Transplant 14 (1999) 946-951
40. Uehara T., Watanabe H., Itoh F., Inoune S., Koshida H., Nakamura M., et al. Nephrotoxin of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats. Arch Toxicol 79 (2005) 451-460
41. Ulker S., McMaster D., McKeown P.P., and Bayraktutan U. Antioxidant vitamin C and E ameliorate hyperglycaemia induced oxidative stress in coronary endothelial cells. Diabetes Obesity Metab 6 (2004) 442-451
42. Winters R.A., Ukowski J., Ercal N., Matthews R.H., and Spitz D.R. Analysis of glutathione, glutathione disulfide, cysteine, homocysteine, and other biological thiols by high performance liquid chromatography following derivatization by N-(1-pyrenyl)maleimide. Anal Biochem 227 (1995) 14-21
43. Young I.S., and Woodside J.V. Antioxidants in health and disease. J Clin Pathol 54 (2001) 176-186
44. Zicca A., Cafaggi S., Mariggio M.A., Vanonozzi M.O., Ottone M., Bocchini V., et al. Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats. Eur J Pharmacol 442 (2002) 265-272